Dominic Borie
Direttore Tecnico/Scientifico/R&S presso KYVERNA THERAPEUTICS, INC.
Patrimonio netto: 6 M $ in data 31/05/2024
Posizioni attive di Dominic Borie
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 13/10/2022 | - |
| Direttore/Membro del Consiglio | 01/01/2020 | 13/10/2022 | |
| Amministratore Delegato | 01/01/2020 | 13/10/2022 | |
| Presidente | 01/01/2020 | 13/10/2022 |
Storia della carriera di Dominic Borie
Precedenti posizioni note di Dominic Borie
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Stanford University | Corporate Officer/Principal | - | - |
| AMGEN INC. | Direttore Tecnico/Scientifico/R&S | - | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
| ALLOGENE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - | - |
Formazione di Dominic Borie
| The University of Texas at Austin | Doctorate Degree |
| North Carolina State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Irlanda | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| KYVERNA THERAPEUTICS, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Dominic Borie
- Esperienza
